WO2013013648A1 - Implantat - Google Patents
Implantat Download PDFInfo
- Publication number
- WO2013013648A1 WO2013013648A1 PCT/DE2011/001539 DE2011001539W WO2013013648A1 WO 2013013648 A1 WO2013013648 A1 WO 2013013648A1 DE 2011001539 W DE2011001539 W DE 2011001539W WO 2013013648 A1 WO2013013648 A1 WO 2013013648A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- magnesium
- fibers
- implant
- implant according
- based alloy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
- A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
- A61B17/68—Internal fixation devices, including fasteners and spinal fixators, even if a part thereof projects from the skin
- A61B17/80—Cortical plates, i.e. bone plates; Instruments for holding or positioning cortical plates, or for compressing bones attached to cortical plates
- A61B17/8085—Cortical plates, i.e. bone plates; Instruments for holding or positioning cortical plates, or for compressing bones attached to cortical plates with pliable or malleable elements or having a mesh-like structure, e.g. small strips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/04—Metals or alloys
- A61L27/047—Other specific metals or alloys not covered by A61L27/042 - A61L27/045 or A61L27/06
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/148—Materials at least partially resorbable by the body
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
- B22F1/06—Metallic powder characterised by the shape of the particles
- B22F1/062—Fibrous particles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F9/00—Making metallic powder or suspensions thereof
- B22F9/02—Making metallic powder or suspensions thereof using physical processes
- B22F9/06—Making metallic powder or suspensions thereof using physical processes starting from liquid material
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22C—ALLOYS
- C22C49/00—Alloys containing metallic or non-metallic fibres or filaments
- C22C49/14—Alloys containing metallic or non-metallic fibres or filaments characterised by the fibres or filaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00004—(bio)absorbable, (bio)resorbable, resorptive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00526—Methods of manufacturing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/3006—Properties of materials and coating materials
- A61F2002/30062—(bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2002/3092—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth having an open-celled or open-pored structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/3094—Designing or manufacturing processes
- A61F2002/30968—Sintering
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00011—Metals or alloys
- A61F2310/00035—Other metals or alloys
- A61F2310/00041—Magnesium or Mg-based alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
Definitions
- the invention relates to implants that are implanted as temporary implants in living beings and zerset zen by bioresorption over a period of time in the body.
- the wires should be folded and / or rolled up as knitwear and then processed by pressing into a shaped body.
- the possibility of the geometric design of such an implant is limited and it is in each case a specific molding and pressing tool for an implant required. It is also described how holes can be made.
- a certain insertion of the wires in the mold is usually required, in which the arrangement of a bore is taken into account.
- a corresponding, adapted to the desired shape of the implant pressing tool is required.
- the wires used must have a certain length sufficient to achieve a secure connection, which is problematic in magnesium and magnesium alloys, especially in the desired deformation during pressing.
- the flexible deformability of such implants has a disadvantageous effect due to their flexibility, since the wires are not firmly connected to one another.
- the implant according to the invention consists of magnesium or a magnesium-based alloy. It is formed from Fa ⁇ fibers of magnesium or a magnesium-based alloy, which are connected by locally spaced sintering bridges with one another so that they form an open-pore body.
- the fibers should have a length in the range of 2 mm to 15 mm, preferably in the range of 5 mm to 10 mm and / or an outer diameter in the range of 0.05 mm to 0.5 mm. As a result, they can be produced inexpensively and simply processed further.
- the magnesium base alloy is formed with at least one metal with which a liquid phase can be formed at a temperature below the melting temperature of the pure magnesium. This also makes it possible that the proportion of the liquid phase formed can be kept less than 20%. Thus, once a secure connection of the fibers on the sintered bridges at the contact positions and also a sufficient de strength of the fiber composite can be achieved.
- At least one metal selected from Y, Zn, Ca, Mn, Pd, Ag, Sr, Bi, Si Pr, Ga, Sc, Zr, Ce, Eu, La may be contained in a magnesium base alloy.
- Nd, Na and Li may be contained in a magnesium base alloy.
- a magnesium-based alloy should be understood as meaning an alloy in which the proportion of magnesium is greater than 50%, preferably greater than 75%.
- the implant should have a porosity in the range of 50% to 95%. On its own or in addition, it should have a volume-specific surface area in the range of 5000 m 2 / m 3 to 50 000 mVm 3 .
- a magnesium oxide layer and / or a fluoride layer is formed on the surface of the fibers.
- Fluo ⁇ the degradation can be influenced, with which the implant is absorbed in a living body so that it is therefore no surgical removal is no longer necessary and thus completely without residue absorbed after a predeterminable period of time and accordingly.
- Suitable fluorides are, for example, magnesium and sodium fluoride.
- Regions with different porosity and strength can also be present on an implant, so that adaptation to a particular desired application is possible.
- the packing density of fibers and thus the porosity in the respective areas can vary.
- the strength can be increased in such a region and correspondingly reduced in other preparation ⁇ chen. That too
- the ingrowth behavior of tissue can thus be specifically influenced locally.
- the fibers thus produced are placed in a bed on a substrate or in a form consisting of an inert material, and then sintering takes place in an inert atmosphere, in which the fibers are connected to one another via locally spaced-apart sintered bridges.
- a magnesium-based alloy sintering below the
- Melting temperature of the pure magnesium can be carried out, since the desired liquid melt phase, which can be achieved for a desirable liquid phase sintering in Be ⁇ rich trainees the Sinter Hampshiren, with a suitably selected magnesium-based alloy, at a correspondingly reduced temperature.
- the already mentioned magnesium oxide layer on the surface of the fibers can be formed by means of an anodic oxidation, a plasma chemical oxidation or a thermal oxidation. This is done after the sintering process.
- An open-pore body which can be used in the invention, as an implant according to the invention, can also be applied to a further, preferably preferred metallic implant (for example a prosthesis) which is not or only slightly porous, and preferably bonded to it in a materially bonded manner. This can improve the ingrowth of tissue or bone as well as a bony anchorage.
- An implant according to the invention can be referred to as a temporary implant, which is then connected to a permanent implant (eg a hip prosthesis socket).
- the Mg fiber braid which is fast due to the degradation, enables a better grow a bone and thereby a faster secure anchoring of the hip stem can be achieved.
- MgY4 (4 mass% yttrium balance magnesium) are produced by the melt extraction process metallic short fibers.
- the magnesium base alloy is melted inductively in a Ni-free steel crucible at a temperature of 680 ° C.
- the extraction roller dips into the
- the melt extraction system is equipped with argon Inert gas is flooded so that the fibers are extracted in an inert atmosphere.
- Table 1 contains the most important data on the melt extraction of various MgY4 fiber batches and Table 2 the characteristic fiber characteristics.
- Example 1 MgY4 fibers are prepared without Schmelzbadabdeckung having a mean circular equivalent diameter of 216 ⁇ 68 ⁇ and an average fiber length of 7.2 mm. These fibers are characterized by a high purity comparable to that of the starting material (Schmelzingot). In the overall analysis, oxygen is determined to be ⁇ 0.002%.
- a defined fiber bed is produced before the actual sintering process. This is done by means of a sieve (Siebtrom ⁇ mel for large samples). The fibers are singulated and placed evenly layer by layer on a sintered substrate. Subsequently, the fibers are sintered in the furnace using parameters which make it possible to achieve a highly porous and at the same time solid sintered composite.
- the sintering takes place below the melting temperature of the magnesium-base alloy at a temperature of 625 ° C to 630 ° C, at which temporary liquid phases form.
- a liquid phase fraction of between 10% and 20% in the region of the sintering temperature has a favorable effect on achieving a stable sintering composite and is a prerequisite for the sintering of materials with surface oxide formation, as is the case with Mg.
- the fibers should not react with the sintered substrate, which also means that the ge ⁇ sintered sample, should easily be solved by the sintered base. For this reason, the MgY4 fibers were deposited on an inert pad of tantalum sheet in such a way that the structure has the desired porosity of 75% after sintering. Tantalum backing and cover plate ensure that the chemical composition of the fibers does not change during sintering.
- the sintering took place in a protective gas furnace (quartz glass tube) under high-purity argon 6.0 by heating the sample at 10 K / min up to 600 ° C, with a holding time of 1 min and subsequent further heating at 3 K / min up to the sintering temperature ⁇ ⁇ of 628 ° C.
- titanium was used as Getter material used.
- the sintered structure is characterized by stable sintered contacts in the area of sintered bridges, a high average porosity of 73.5% and very good
- open-pored moldings can be done by sawing (dry) or laser cutting.
- Open-pored bodies of defined geometry eg. B. round blanks with a diameter of 10 mm, were prepared by laser cutting under argon inert gas.
- Example 2 An open porous body sintered in accordance with Example 1 was superficially oxidized after sintering by the action of oxygen at a temperature below the sintering temperature. Since the oxidation after the When sintering occurs, the formed oxide layer does not damage the sintered bridges between the fibers.
- the corrosion test in DMEM shows for this sample an improved stability, ie slowed down resolution (degradation) of the fiber composite.
- MgY4 fibers are produced analogously to Example 1.
- a molten bath covering was applied by placing iron-based hollow spheres loosely on the metal to be melted, but covering the surface.
- the hollow spheres float on the molten bath without dissolving in it. They thus significantly reduce the evaporation of the melt within the extraction plant.
- the fibers of MgY4 produced in this way have a mean circular equivalent diameter of 187 ⁇ 63 ⁇ m and an average fiber length of 5.8 mm. These fibers are also characterized by a high purity.
- the chemical analysis of the fibers compared to the melting ingot MgY4 shows no significant changes in the content of Y and no increase in the unwanted elements Al, Cu or Fe. The latter are present in the starting material in contents ⁇ 0.004 or 0.005%.
- Tantalum sheet which was coated with a MgO suspension, sintered.
- the suspension which consists of powder Magnesia 298, dispersed in ethanol, is burnt out at 800 ° C. under argon protective gas. This achieves a high-purity coating.
- An advantage of this MgO coating is that the open-pored body formed with the sintered fibers can be easily detached after sintering. The subsequent handling is much easier.
- a possible “anchoring" of the fine MgO powder particles at the outer fiber zone of the open-pored body as a result of the sintering process has an advantageous effect on the corrosion behavior, and a slight reduction in the corrosion rate was observed so that the degradation should take place over a relatively long period of time ,
- magnesium-magnesium alloy fibers MgY4 are poured into a highly porous structure and sintered.
- the sintered open-pore body is subjected to a plasma-chemical oxidation.
- An oxide layer forms on the surface of the fiber structure. This causes the corrosion in DMEM (version see Example 1) to proceed much more slowly.
- Table 1 extraction conditions; Fibers MgY4 (3 examples)
- the base alloy MgY4 (4% by mass of yttrium) was melted with the addition of high-purity Ca granules in a high-vacuum melting and casting plant to form a MgYCa alloy. For thorough mixing of the components, the ingredients were remelted several times. The finished fuming ingot was analyzed with regard to the element contents and possibly kept impurities. The analyzes yielded on average 2.6% yttrium and 1.6% calcium. For the unwanted accompanying elements Cu and Fe, contents ⁇ 0.004 and ⁇ 0.003% were determined. The oxygen content was max. 0.01%.
- fibers of this alloy MgY2,6Cal, 6 are produced. Ie. The fiber production was carried out with molten bath covering, by iron-based hollow spheres on the molten bath and during the
- MgY2, 6Cal, 6 ⁇ batch V620 have a mean circular equivalent diameter of 166 ⁇ 75 ⁇ m and an average fiber length of 7.4 mm. These fibers are also characterized by a high purity. The chemical analysis of the fibers compared to
- Schmelzingot MgY4 shows no significant changes in the content of Y and no appreciable raised stabili ⁇ hung the undesirable elements Cu or Fe, for Cu were 0.004% and 0.007% determined for Fe.
- Fibers prepared analogously to Example 6 are poured into a highly porous structure analogously to Example 1 and sintered. Taking into account the ternary phase diagram and thermodynamic calculations for
- the sintering was carried out as described in Example 1 in a protective gas furnace (quartz glass tube) under high purity argon 6.0 by heating the sample at 10 K / min to 550 ° C, holding time 1 min, and then heating at 3 K / min to the sintering temperature T m ax of 580 ° C, holding time 20 min.
- Sintered contacts a high porosity of 61% in the pro- benffen and very good workability.
- the processing of 'defined moldings in the form of Ron- the diameter of 10 mm was made by laser cutting.
- the sintered structure is characterized by a high degree of purity (oxygen content not exceeding 0.001%). Due to the changed composition (2.6% Y, 1.6% Ca), the rate of degradation measurable in the corrosion test is somewhat higher than in the case of the implant obtained according to Example 1.
- the implants prepared in Examples 1 to 7 can be cleaned and then coated as follows. For cleaning, mix 20ml glycerol (85%), 5ml nitric acid (65%), 5ml acetic acid (100%) and place the sintered implant in the
- the thus cleaned and dried implant can be immersed in a saturated sodium fluoride solution. 4 g in 100 ml of Aqua ad iniectabilia (Fa Braun, 100 ml glass bottle) are added to the solution, and the mixture is placed in a glass vessel and stirred there for a period of 1 to 2 hours. The pH is adjusted to 11 by addition of NaOH. 5. The implant can be placed in the solution thus obtained and a sodium fluoride coating can be applied the surface are formed. After drying in a vacuum cabinet, the sodium fluoride coating had an average layer thickness of at least 0.1 ⁇ . It was possible with the coating to achieve a significant reduction in the corrosion rate in comparison with an uncoated fiber structure.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Surgery (AREA)
- Cardiology (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Materials Engineering (AREA)
- Mechanical Engineering (AREA)
- Metallurgy (AREA)
- Neurology (AREA)
- Nanotechnology (AREA)
- Dispersion Chemistry (AREA)
- Materials For Medical Uses (AREA)
- Powder Metallurgy (AREA)
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11787580.7A EP2736431B1 (de) | 2011-07-27 | 2011-07-27 | Implantat |
PCT/DE2011/001539 WO2013013648A1 (de) | 2011-07-27 | 2011-07-27 | Implantat |
ES11787580.7T ES2651013T3 (es) | 2011-07-27 | 2011-07-27 | Implante |
KR1020147005003A KR101901638B1 (ko) | 2011-07-27 | 2011-07-27 | 임플란트 |
JP2014521948A JP5846591B2 (ja) | 2011-07-27 | 2011-07-27 | インプラント |
US14/234,681 US10709816B2 (en) | 2011-07-27 | 2011-07-27 | Implant |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/DE2011/001539 WO2013013648A1 (de) | 2011-07-27 | 2011-07-27 | Implantat |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2013013648A1 true WO2013013648A1 (de) | 2013-01-31 |
Family
ID=45023453
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE2011/001539 WO2013013648A1 (de) | 2011-07-27 | 2011-07-27 | Implantat |
Country Status (6)
Country | Link |
---|---|
US (1) | US10709816B2 (de) |
EP (1) | EP2736431B1 (de) |
JP (1) | JP5846591B2 (de) |
KR (1) | KR101901638B1 (de) |
ES (1) | ES2651013T3 (de) |
WO (1) | WO2013013648A1 (de) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2899266A1 (de) * | 2014-01-24 | 2015-07-29 | Fresenius Medical Care Deutschland GmbH | Verbesserte Differenzierung mesenchymaler Stammzellen zu Osteoblasten |
US10709816B2 (en) | 2011-07-27 | 2020-07-14 | Medizinische Hochschule Hannover (Mhh) | Implant |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE112014007192T5 (de) * | 2014-12-25 | 2017-08-24 | Olympus Corporation | Osteosynthetisches Implantat und Herstellungsverfahren hierfür |
WO2018187407A1 (en) * | 2017-04-04 | 2018-10-11 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Mg alloy mesh reinforced polymer/ecm hybrid scaffolds for critical-sized bone defect regeneration |
WO2022098062A1 (ko) | 2020-11-04 | 2022-05-12 | 한국재료연구원 | 고강도 고내식 생분해성 마그네슘 합금 및 이를 이용하는 임플란트 |
DE102021203391A1 (de) * | 2021-04-06 | 2022-10-06 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung eingetragener Verein | Verfahren zur Herstellung von offenporösen Knochenimplantaten aus Fasern, mit frei zugänglichen Leitstrukturen aus Fasern, die aus einem biokompatiblen Metall oder Metalllegierung gebildet sind |
US20220354487A1 (en) | 2021-05-10 | 2022-11-10 | Cilag Gmbh International | Method for implementing a staple system |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1000097B (de) | 1953-03-30 | 1957-01-03 | Licentia Gmbh | Verwendung von Trockengleichrichter-anordnungen zum Stabilisieren einer Gleichspannung |
DE19712625A1 (de) * | 1997-03-26 | 1998-10-01 | Fraunhofer Ges Forschung | Verfahren und Vorrichtung zur Herstellung eines Faserformkörpers |
WO2003055537A2 (de) * | 2001-12-24 | 2003-07-10 | Universität Hannover | Medizinische implantate, prothesen, protheseteile, medizinische instrumente, geräte und hilfsmittel aus einem halogenid-modifizierten magnesiumwerkstoff |
DE10241572A1 (de) * | 2002-09-07 | 2004-03-25 | Werner Scholz | Stütz- oder Halteteil zum Einbringen in ein Knochenteil |
DE102006005510A1 (de) | 2006-02-01 | 2007-08-09 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Vorrichtung und Verfahren zur Herstellung metallischer Fasern durch Schmelzextraktion |
DE102008046197B3 (de) * | 2008-09-05 | 2009-12-24 | Verein zur Förderung von Innovationen durch Forschung, Entwicklung und Technologietransfer e.V. (Verein INNOVENT e.V.) | Degradierbares Implantat und Verfahren zu seiner Herstellung sowie deren Verwendung |
DE102008037204A1 (de) | 2008-08-11 | 2010-02-25 | Alfred Buck | Platte zur Fixierung von Knochenfragmenten |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6240616B1 (en) * | 1997-04-15 | 2001-06-05 | Advanced Cardiovascular Systems, Inc. | Method of manufacturing a medicated porous metal prosthesis |
US6365092B1 (en) * | 1999-06-23 | 2002-04-02 | Abb Lummus Global, Inc. | Method for producing a sintered porous body |
US6395168B1 (en) * | 1999-11-19 | 2002-05-28 | Terra Group, Corp. | Reticulated liquid treatment device |
FR2825378B1 (fr) | 2001-05-31 | 2003-11-28 | Univ Paris Curie | Composition et procede pour le traitement d'alliages de magnesium |
US20050163821A1 (en) * | 2002-08-02 | 2005-07-28 | Hsing-Wen Sung | Drug-eluting Biodegradable Stent and Delivery Means |
DE102005003188A1 (de) * | 2005-01-20 | 2006-07-27 | Restate Patent Ag | Medizinisches Implantat aus einer amorphen oder nanokristallinen Legierung |
CA2612195A1 (en) * | 2005-07-01 | 2007-01-11 | Cinvention Ag | Medical devices comprising a reticulated composite material |
US8048150B2 (en) * | 2006-04-12 | 2011-11-01 | Boston Scientific Scimed, Inc. | Endoprosthesis having a fiber meshwork disposed thereon |
CN101484599A (zh) * | 2006-04-28 | 2009-07-15 | 生物镁***有限公司 | 生物可降解的镁合金及其用途 |
US8057534B2 (en) * | 2006-09-15 | 2011-11-15 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
WO2008122594A2 (en) * | 2007-04-05 | 2008-10-16 | Cinvention Ag | Partially biodegradable therapeutic implant for bone and cartilage repair |
CN102725006B (zh) * | 2009-10-07 | 2014-10-22 | 百傲图科技有限公司 | 多孔性组织支架 |
WO2011157758A1 (de) * | 2010-06-15 | 2011-12-22 | Innotere Gmbh | Knochenimplantat, enthaltend einen magnesiumhaltigen metallischen werkstoff mit verminderter korrosionsrate und verfahren und set zu dessen herstellung |
WO2012003502A2 (en) * | 2010-07-02 | 2012-01-05 | University Of Florida Research Foundation, Inc. | Bioresorbable metal alloy and implants made of same |
US10709816B2 (en) | 2011-07-27 | 2020-07-14 | Medizinische Hochschule Hannover (Mhh) | Implant |
-
2011
- 2011-07-27 US US14/234,681 patent/US10709816B2/en active Active
- 2011-07-27 WO PCT/DE2011/001539 patent/WO2013013648A1/de active Application Filing
- 2011-07-27 ES ES11787580.7T patent/ES2651013T3/es active Active
- 2011-07-27 KR KR1020147005003A patent/KR101901638B1/ko active IP Right Grant
- 2011-07-27 JP JP2014521948A patent/JP5846591B2/ja active Active
- 2011-07-27 EP EP11787580.7A patent/EP2736431B1/de active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1000097B (de) | 1953-03-30 | 1957-01-03 | Licentia Gmbh | Verwendung von Trockengleichrichter-anordnungen zum Stabilisieren einer Gleichspannung |
DE19712625A1 (de) * | 1997-03-26 | 1998-10-01 | Fraunhofer Ges Forschung | Verfahren und Vorrichtung zur Herstellung eines Faserformkörpers |
WO2003055537A2 (de) * | 2001-12-24 | 2003-07-10 | Universität Hannover | Medizinische implantate, prothesen, protheseteile, medizinische instrumente, geräte und hilfsmittel aus einem halogenid-modifizierten magnesiumwerkstoff |
DE10241572A1 (de) * | 2002-09-07 | 2004-03-25 | Werner Scholz | Stütz- oder Halteteil zum Einbringen in ein Knochenteil |
DE102006005510A1 (de) | 2006-02-01 | 2007-08-09 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Vorrichtung und Verfahren zur Herstellung metallischer Fasern durch Schmelzextraktion |
DE102008037204A1 (de) | 2008-08-11 | 2010-02-25 | Alfred Buck | Platte zur Fixierung von Knochenfragmenten |
DE102008046197B3 (de) * | 2008-09-05 | 2009-12-24 | Verein zur Förderung von Innovationen durch Forschung, Entwicklung und Technologietransfer e.V. (Verein INNOVENT e.V.) | Degradierbares Implantat und Verfahren zu seiner Herstellung sowie deren Verwendung |
Non-Patent Citations (2)
Title |
---|
GÜNTER STEPHANI ET AL: "New multifunctional lightweight materials based on cellular metals - manufacturing, properties and applications", JOURNAL OF PHYSICS: CONFERENCE SERIES, vol. 165, 1 May 2009 (2009-05-01), pages 012061, XP055024406, DOI: 10.1088/1742-6596/165/1/012061 * |
OLAF ANDERSEN: "Aluminiumfaser-Strukturen für Adsorptions-Kältemaschinen", 6 April 2011 (2011-04-06), pages 1 - 2, XP055024408, Retrieved from the Internet <URL:http://www.ifam-dd.fraunhofer.de/content/dam/ifam-dd/de/documents/Dokumente ZMW/Fachinfo_Adsorptionskaelte.pdf> [retrieved on 20120413] * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10709816B2 (en) | 2011-07-27 | 2020-07-14 | Medizinische Hochschule Hannover (Mhh) | Implant |
EP2899266A1 (de) * | 2014-01-24 | 2015-07-29 | Fresenius Medical Care Deutschland GmbH | Verbesserte Differenzierung mesenchymaler Stammzellen zu Osteoblasten |
Also Published As
Publication number | Publication date |
---|---|
US10709816B2 (en) | 2020-07-14 |
ES2651013T3 (es) | 2018-01-23 |
EP2736431A1 (de) | 2014-06-04 |
EP2736431B1 (de) | 2017-09-06 |
KR20140078611A (ko) | 2014-06-25 |
JP2014528740A (ja) | 2014-10-30 |
US20140324188A1 (en) | 2014-10-30 |
JP5846591B2 (ja) | 2016-01-20 |
KR101901638B1 (ko) | 2018-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2736431B1 (de) | Implantat | |
EP2104471B1 (de) | Dentalimplantat und verfahren zu dessen herstellung | |
EP1212160B1 (de) | Gemisch aus zwei teilchen-phasen zur herstellung eines bei höheren temperaturen sinterfähigen grünlings | |
EP2944401B1 (de) | Verfahren zur Herstellung eines Bauteils aus einer Metalllegierung mit amorpher Phase | |
EP2974812B1 (de) | Verfahren zur Herstellung eines Bauteils aus einer Metalllegierung mit amorpher Phase | |
DE102005045698B4 (de) | Formkörper aus einer Dentallegierung zur Herstellung von dentalen Teilen | |
JP2011515145A (ja) | 生体分解性マグネシウム系合金で多孔性構造体の気孔が充填された複合材インプラントおよびその製造方法 | |
de Oliveira et al. | Study of the porous Ti35Nb alloy processing parameters for implant applications | |
EP0366018B1 (de) | Metallspongiosa und Verfahren zu ihrer Herstellung | |
WO2013029589A1 (de) | Oberflächenpassivierung von aluminiumhaltigem pulver | |
DE3438547C2 (de) | Wärmebehandlungsverfahren für vorlegierte, zweiphasige Wolframpulver | |
DE102010018303B4 (de) | Schmelzverfahren zur Herstellung einer einschlussfreien Ta-Basislegierung für eine implantierbare medizinische Vorrichtung | |
WO2021058702A1 (de) | Metallkörper und verfahren zu ihrer herstellung | |
EP0525325B1 (de) | Verfahren zur Herstellung dichter Sinterwerkstücke | |
WO2021094560A1 (de) | Sphärisches pulver zur fertigung von dreidimensionalen objekten | |
DE19626656C2 (de) | Beschichtete Gußform aus feuerfester Keramik und Verfahren zu ihrer Herstellung | |
EP2976311B1 (de) | Sinter- und/oder schmelzfähige keramische masse, deren herstellung und verwendung | |
KR101485296B1 (ko) | 생체분해성 임플란트 및 이의 제조방법 | |
DE102009054605B3 (de) | Offenzellige Titan-Metallschäume | |
DE3808123A1 (de) | Verfahren zur herstellung von sinterteilen aus feinkoernigen metall- oder keramikpulvern | |
WO2013004637A2 (de) | Verfahren zur herstellung einer porösen keramik | |
DE29623992U1 (de) | Beschichtete Gußform aus feuerfester Keramik | |
DD293957A5 (de) | Verfahren zur herstellung von metallspongiosa | |
DE10163713A1 (de) | Verfahren zur Herstellung von Metallpulvern |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11787580 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2014521948 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1120111054696 Country of ref document: DE |
|
REEP | Request for entry into the european phase |
Ref document number: 2011787580 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 20147005003 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14234681 Country of ref document: US |